Thrombocytopenic purpura is a bleeding disorder characterized by bleeding of the skin and mucous membranes due to thrombocytopenia. Patients with thrombocytopenic purpura are advised to actively cooperate with their doctors for treatment, and patients with aggressive conditions may be at risk of death without treatment. Thrombocytopenic purpura is a bleeding disorder characterized by skin and mucous membrane bleeding due to thrombocytopenia. In addition to bleeding symptoms, patients may also have microangiopathic hemolysis, neurological abnormalities, renal damage and fever. The main symptoms are bleeding, fatigue, headache, disturbance of consciousness, yellowing of the skin and sclera, proteinuria, hematuria and fever. Thrombocytopenic purpura can be treated with drugs (prednisone, gammaglobulin) and surgery (splenectomy) to bring the patient’s platelet count up to a safe level and to reduce the mortality rate. Patients with aggressive disease need to be treated as soon as possible to avoid delays. Specific medications need to be administered under the direction of a physician.